Physician profile
William Daniel White
NPI 1982100483
$2,441.48
in general payments reported to CMS, 2019-2025
8 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $718 · 2024: $598 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262 · Travel and Lodging: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.23 |
| Travel and Lodging | $1,179.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,061.24 | 2023-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $126.28 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Mml US, INC. | $107.02 | 2025 | Reactiv8 |
| Painteq LLC | $45.56 | 2023 | Painteq |
| Collegium Pharmaceutical, INC. | $41.17 | 2024 | Belbuca |
| Abbvie INC. | $26.41 | 2023 | Botox |
| Philips North America LLC | $19.58 | 2025 | Ecc Solutions |
| Curonix LLC | $14.22 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.